XTL Biopharmaceuticals Vs. Pluri Industry Stock Comparison

Sell

20

XTLB
XTL Biopharmaceuticals

Last Price:

1.88

Seasonality Move:

6.1%

Sell

41

PLUR
Pluri

Last Price:

4.85

Seasonality Move:

10.98%

Sell

20

XTL Biopharmaceuticals (XTLB) is a Sell

Is XTL Biopharmaceuticals a Buy, Sell or Hold?

The current XTL Biopharmaceuticals [XTLB] share price is $1.88. The Score for XTLB is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
XTLB is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

Sell

41

Pluri (PLUR) is a Sell

Is Pluri a Buy, Sell or Hold?

The current Pluri [PLUR] share price is $4.56. The Score for PLUR is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
PLUR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

XTLB Stock Price Chart

What is XTL Biopharmaceuticals's stock price today?

The XTL Biopharmaceuticals share price today is $1.88
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XTLB is experiencing slight selling pressure.

PLUR Stock Price Chart

What is Pluri's stock price today?

The Pluri share price today is $4.56
The current trend is relatively stagnant and PLUR is experiencing selling pressure, which indicates risk of future bearish movement.

XTLB Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.11	Sell
Relative Strength Index (14 RSI):	45.64	Sell
Chaikin Money Flow:	-24344	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(1.75 - 2.35)	Sell
Bollinger Bands (100):	(2.11 - 2.75)	Sell

PLUR Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.16	Sell
Relative Strength Index (14 RSI):	43.17	Sell
Chaikin Money Flow:	-45793	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(4.51 - 5.29)	Sell
Bollinger Bands (100):	(4.95 - 5.77)	Sell

XTLB Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	1.86	Buy
20-day SMA:	1.97	Sell
50-day SMA:	2.32	Sell
200-day SMA:	2.17	Sell
8-day EMA:	1.96	Sell
20-day EMA:	2.01	Sell
50-day EMA:	2.22	Sell
200-day EMA:	2.14	Sell

PLUR Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	4.6	Sell
20-day SMA:	4.75	Sell
50-day SMA:	5.18	Sell
200-day SMA:	5.73	Sell
8-day EMA:	4.69	Sell
20-day EMA:	4.8	Sell
50-day EMA:	5.08	Sell
200-day EMA:	5.52	Sell

XTL Biopharmaceuticals Earnings Growth & XTLB Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Pluri Earnings Growth & PLUR Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

XTL Biopharmaceuticals Technical Analysis

	Oct 22	Oct 23	Oct 24	Oct 25	Oct 28	Oct 29	Oct 30	Oct 31	Nov 1	Nov 4
	Oct									Nov
	22	23	24	25	28	29	30	31	01	04
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Pluri Technical Analysis

	Oct 22	Oct 23	Oct 24	Oct 25	Oct 28	Oct 29	Oct 30	Oct 31	Nov 1	Nov 4
	Oct									Nov
	22	23	24	25	28	29	30	31	01	04
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):